Improvement of Hailey-Hailey disease with abrocitinib.
Clinical and experimental dermatology(2023)
摘要
We describe a patient with classical Hailey–Hailey disease who was successfully treated with the Janus kinase (JAK)1 inhibitor abrocitinib. To our knowledge, abrocitinib has not previously been described in the medical literature as a treatment option for HHD.
更多查看译文
关键词
hailey–hailey disease,abrocitinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要